세계의 항바이러스제 시장 : 유형별, 용도별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Antiviral Drugs Market, By Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,475,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,403,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,781,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 하이라이트

세계 항바이러스제 시장 규모는 2022년 684억 3,040만 달러로 2023년부터 2030년까지 연평균 2.1%의 성장률을 보일 것으로 예상됩니다.

항바이러스제 시장 - 시장 역학

바이러스성 질환의 유행과 항바이러스제 시장 개척으로 시장 수요 촉진

예측 기간 동안 바이러스 감염에 대한 인식이 높아지고 다양한 예방접종과 바이러스성 질환의 유병률 증가로 인해 항바이러스제의 제네릭 버전이 출시되면서 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다. 세계보건기구(WHO)는 전 세계적으로 3억 2,500만 명이 간염에 감염되어 있으며, 그 중 약 7,100만 명이 C형 간염 바이러스(HCV)에 만성적으로 감염되어 있는 것으로 추정하고 있습니다. 또한 미국 보건복지부는 국내 85만 명이 B형 간염에, 240만 명이 C형 간염에 감염된 것으로 집계하고 있습니다. 따라서 환자 수 증가에 따라 국제적으로 항바이러스제에 대한 수요가 증가할 것으로 예상됩니다.

항바이러스제 시장 - 주요 인사이트

• 세계 시장은 예측 기간(2023-2030년) 동안 연평균 2.1%의 CAGR로 성장할 것으로 예상됩니다.
• 유형별 세분화에서는 바이러스 치료에서 브랜드 치료제의 높은 채택률로 인해 합성 브랜드 부문이 2022년에 가장 큰 시장 점유율을 보일 것으로 예상됩니다.
• 용도별 세분화에서 HIV 치료제는 주로 항레트로바이러스 치료제에 대한 수요 증가로 인해 2022년 주요 유형이었습니다.
• 유통 채널별 세분화에서 병원 약국은 주로 입원 치료의 필요성으로 인해 2022년 주요 유형이었습니다.
• 지역별로는 기술적으로 진보된 생산 설비를 이용할 수 있는 북미가 2022년 주요 수익원이었습니다.

항바이러스제 시장 - 세분화 분석:

• 항바이러스제 세계 시장은 유형, 용도, 유통 채널 및 지역에 따라 세분화됩니다.
• 유형별로는 브랜드 의약품과 제네릭 의약품으로 나뉩니다. 브랜드 제품이 시장을 독점하고 있습니다. 기술 개발, 신약에 대한 관심이 높아짐에 따라 시장 성장에 기여할 것으로 보입니다.
• 시장은 용도별로 5가지(HIV, 간염, 헤르페스, 헤르페스, 인플루엔자, 기타)로 분류되며, HIV 분야는 시장을 독점하고 있으며, 예측 기간 동안에도 그 우위를 유지할 것으로 보입니다. 항바이러스제는 치료제를 통해 HIV 바이러스 감염을 치료하는 데 중요한 역할을 하고 있습니다.
• 시장은 유통 채널에 따라 병원 약국, 소매 약국, 온라인 약국 등 세 가지로 나뉩니다. 병원 약국은 시장을 독점하고 있으며 예측 기간 동안 그 우위를 유지할 것으로 보입니다. 온라인 약국은 온라인 E-Commerce의 혜택을 받아 빠른 속도로 견인력을 높이고 있습니다.

항바이러스제 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이들 지역은 사업 운영 국가에 따라 더 세분화되어 있습니다.

항바이러스제 시장 - 경쟁 상황:

시장 점유율을 확대하기 위해 기업들은 제품 라인 확장을 목적으로 합작 투자, 합병, 인수, 임상시험, 전략적 협약 등의 전략적 이니셔티브를 추진하고 있습니다. 또한, 시장 진입 기업들은 세계 시장에서의 입지를 유지하기 위해 식품 알레르기 제품 출시 및 세계 진출에 주력하고 있습니다. 세계 항바이러스제 시장은 지지적인 FDA, 미국 및 정부와의 협력 관계로 인해 더욱 영향을 받고 있습니다. 예를 들어, 2021년 12월 머크는 Ridgeback Biotherapeutics와 협력하여 COVID-19의 저강도 및 고강도 치료를 위한 경구용 항바이러스제 몰누피라비르(molnupiravir)에 대한 FDA 승인을 획득했습니다.

목차

제1장 항바이러스제 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 항바이러스제의 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 항바이러스제 산업 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 체계 분석

제5장 항바이러스제 시장 : COVID-19의 영향 분석

• COVID-19 이전의 영향 분석
• COVID-19 이후의 영향 분석

제6장 항바이러스제 시장 상황

• 항바이러스제 시장 점유율 분석, 2022년
• 내역 데이터 : 주요 제조업체별
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 항바이러스제 시장 : 유형별

• 개요
  • 부문 점유율 분석 : 유형별
  • 브랜드
  • 제네릭

제8장 항바이러스제 시장 : 용도별

• 개요
  • 부문 점유율 분석 : 용도별
  • HIV
  • 간염
  • 포진
  • 인플루엔자
  • 기타

제9장 항바이러스제 시장 : 유통 채널별

• 개요
  • 부문 점유율 분석 : 유통 채널별
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제10장 항바이러스제 시장 : 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석 : 항바이러스제 업계

• 경쟁 대시보드
• 기업 개요
  • F. Hoffmann-La Roche Ltd.
  • GSK plc.
  • AbbVie, Inc.
  • Merck &Co., Inc.
  • Johnson &Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Ridgeback Biotherapeutics
  • Aurobindo Pharm
  • Dr. Reddy's Laboratories Ltd.
  • Zydus Pharmaceuticals
  • SIGA Technologies
  • Pfizer Inc.
  • NAVINTA LLC
  • Sun Pharma
  • 기타

제12장 애널리스트의 전방위 전망

ksm

영문 목차

영문목차

REPORT HIGHLIGHT

Antiviral Drugs Market size was valued at USD 68,430.4 Million in 2022, expanding at a CAGR of -2.1% from 2023 to 2030.

Antiviral drugs are prescriptions that work by preventing viruses from replicating within the cells that they infect. These medications either stop the virus from entering the host cell or disrupt essential enzymes or proteins needed for viral reproduction. They are designed to target certain viruses or virus species.

Antiviral Drugs Market- Market Dynamics

Increasing prevalence of viral disorders and development in antiviral medicines is to propel market demand

Over the forecast period, rising awareness and availability of different vaccinations for viral infections and the rising prevalence of viral diseases, which has led to the launch of generic versions of antiviral medications, are projected to positively affect the market's growth. The WHO estimates that 325 million individuals worldwide have hepatitis infection, and of those, about 71 million have chronic infection with the Hepatitis C virus (HCV). Furthermore, the U.S. Department of Health and Human Services calculated that 850,000 people in the nation are infected with hepatitis B, and 2.4 million people with hepatitis C. Therefore, it is expected that the demand for antiviral medications will rise internationally as the number of patients grows.

Antiviral Drugs Market- Key Insights

• As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around -2.1% over the forecast period (2023-2030)

• Based on Type segmentation, synthetic branded segment was predicted to show maximum market share in the year 2022, owing to high adoption of branded therapeutics in viral treatment.

• Based on Application segmentation, HIV segment was the leading type in 2022, mainly due to increasing demand for antiretroviral therapy medications.

• Based on Distribution Channel segmentation, hospital pharmacy was the leading type in 2022, mainly due to hospitalization treatment needs.

• On the basis of region, North America was the leading revenue generator in 2022, owing to availability of technologically advanced production facilities.

Antiviral Drugs Market- Segmentation Analysis:

• The Global Antiviral Drugs Market is segmented on the basis of Type, Application, Distribution Channel, and Region.

• The market is divided into four categories based on Type: branded and generics. The branded segment dominates the market. The technology development, growing emphasis on novel therapeutics are likely to contribute to market growth.

• The market is divided into five categories based on Application: HIV, hepatitis, herpes, influenza, and others. The HIV segment dominates the market and is likely to maintain its dominance during the forecast period. Antiviral drugs play crucial role in treatment of HIV viral infections with therapeutic medications.

• The market is divided into three categories based on Distribution Channel: hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy dominates the market and is likely to maintain its dominance during the forecast period. Online pharmacy is gaining more traction at fast pace with online e-commerce benefits.

Antiviral Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antiviral Drugs Market- Competitive Landscape:

To increase their market share, businesses are engaging in strategic initiatives like joint ventures, mergers, acquisitions, clinical trials, and strategic agreements for the purpose of expanding their product line. Industry participants are also focusing on product releases for food allergies and global expansion to maintain their position in the global market. The worldwide antiviral drugs market has been further impacted by supportive FDA, U.S., and government collaborations. For instance, in December 2021, Merck collaborated with Ridgeback Biotherapeutics and established FDA approval for molnupiravir, an oral antiviral agent for backup use to treat low to high COVID-19.

Recent Developments:

In March 2022, Scripps Research, a research & technology and drug discovery organization, and AbbVie Inc. established a strategic collaboration to investigate novel drugs, to provide immediate treatments for COVID-19.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIVIRAL DRUGS MARKET KEY PLAYERS

• F. Hoffmann-La Roche Ltd.
• GSK plc.
• AbbVie, Inc.
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Cipla Inc.
• Ridgeback Biotherapeutics
• Aurobindo Pharm
• Dr. Reddy's Laboratories Ltd.
• Zydus Pharmaceuticals
• SIGA Technologies
• Pfizer Inc.
• NAVINTA LLC
• Sun Pharma
• Others

GLOBAL ANTIVIRAL DRUGS MARKET, BY TYPE

• Branded
• Generics

GLOBAL ANTIVIRAL DRUGS MARKET, BY APPLICATION

• HIV
• Hepatitis
• Herpes
• Influenza
• Others

GLOBAL ANTIVIRAL DRUGS MARKET, BY DISTRIBUTION CHANNEL

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

GLOBAL ANTIVIRAL DRUGS MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Antiviral Drugs Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Antiviral Drugs Market Snippet by Type
  • 2.1.2. Antiviral Drugs Market Snippet by Application
  • 2.1.3. Antiviral Drugs Market Snippet by Distribution Channel
  • 2.1.4. Antiviral Drugs Market Snippet by Country
  • 2.1.5. Antiviral Drugs Market Snippet by Region
• 2.2. Competitive Insights

3. Antiviral Drugs Key Market Trends

• 3.1. Antiviral Drugs Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Antiviral Drugs Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Antiviral Drugs Market Opportunities
• 3.4. Antiviral Drugs Market Future Trends

4. Antiviral Drugs Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Antiviral Drugs Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Antiviral Drugs Market Landscape

• 6.1. Antiviral Drugs Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Antiviral Drugs Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
  • 7.1.2. Branded
  • 7.1.3. Generics

8. Antiviral Drugs Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. HIV
  • 8.1.3. Hepatitis
  • 8.1.4. Herpes
  • 8.1.5. Influenza
  • 8.1.6. Others

9. Antiviral Drugs Market - By Distribution Channel

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
  • 9.1.2. Hospital Pharmacies
  • 9.1.3. Retail Pharmacies
  • 9.1.4. Online Pharmacies

10. Antiviral Drugs Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Antiviral Drugs Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Antiviral Drugs Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Antiviral Drugs Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Antiviral Drugs Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Antiviral Drugs Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antiviral Drugs Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. F. Hoffmann-La Roche Ltd.
  • 11.2.2. GSK plc.
  • 11.2.3. AbbVie, Inc.
  • 11.2.4. Merck & Co., Inc.
  • 11.2.5. Johnson & Johnson Services, Inc.
  • 11.2.6. Bristol-Myers Squibb Company
  • 11.2.7. Cipla Inc.
  • 11.2.8. Ridgeback Biotherapeutics
  • 11.2.9. Aurobindo Pharm
  • 11.2.10. Dr. Reddy's Laboratories Ltd.
  • 11.2.11. Zydus Pharmaceuticals
  • 11.2.12. SIGA Technologies
  • 11.2.13. Pfizer Inc.
  • 11.2.14. NAVINTA LLC
  • 11.2.15. Sun Pharma
  • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료